218 related articles for article (PubMed ID: 32242306)
21. Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma.
Imakura T; Sato S; Tomonari T; Murakami K; Takahashi N; Naito N; Mima M; Kagawa K; Koyama K; Nishimura H; Kawano H; Nokihara H; Azuma M; Takayama T; Nishioka Y
Intern Med; 2022 Apr; 61(8):1211-1217. PubMed ID: 34544944
[TBL] [Abstract][Full Text] [Related]
22. [A Case of Advanced Hepatocellular Carcinoma That Caused Rapid Re-Growth Due to Lenvatinib Withdrawal].
Oyama K; Maeda S; Nakahira S; Kitagawa A; Ushimaru Y; Ohara N; Miyake Y; Makari Y; Nakata K; Fujita J
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1586-1588. PubMed ID: 35046264
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt.
Namba M; Kawaoka T; Aikata H; Kodama K; Uchikawa S; Ohya K; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Baba Y; Awai K; Chayama K
Clin J Gastroenterol; 2019 Aug; 12(4):341-346. PubMed ID: 30706429
[TBL] [Abstract][Full Text] [Related]
24. Acute Acalculous Cholecystitis: Think of Hepatitis A Infection and Do Not Underestimate Pain.
Cortellazzo Wiel L; Spezzacatene A; Gortani G; Saccari A; Taddio A; Barbi E
Pediatr Emerg Care; 2022 Jun; 38(6):304-306. PubMed ID: 35477693
[TBL] [Abstract][Full Text] [Related]
25. A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma.
Aihara Y; Yoshiji H; Yamazaki M; Ikenaka Y; Noguchi R; Morioka C; Kaji K; Tastumi H; Nakanishi K; Nakamura M; Yamao J; Toyohara M; Mitoro A; Sawai M; Yoshida M; Fujimoto M; Uemura M; Fukui H
World J Gastrointest Oncol; 2012 May; 4(5):115-8. PubMed ID: 22645635
[TBL] [Abstract][Full Text] [Related]
26. Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma.
Koizumi Y; Hirooka M; Hiraoka A; Ochi H; Tanaka T; Yukimoto A; Imai Y; Watanabe T; Yoshida O; Miyake T; Matsuura B; Michitaka K; Joko K; Abe M; Hiasa Y
Endocr J; 2019 Sep; 66(9):787-792. PubMed ID: 31142692
[TBL] [Abstract][Full Text] [Related]
27. Development of a thrombus in the superior mesenteric artery associated with sequential therapy with tyrosine kinase inhibitors for hepatocellular carcinoma.
Nawa T; Katayama K; Kiyota R; Imai T; Abe Y; Hasegawa N; Takada R; Fukutake N; Ikezawa K; Sakakibara M; Fujita M; Ohkawa K
Clin J Gastroenterol; 2020 Apr; 13(2):247-251. PubMed ID: 31317371
[TBL] [Abstract][Full Text] [Related]
28. Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
Kodama K; Kawaoka T; Namba M; Uchikawa S; Ohya K; Morio K; Nakahara T; Murakami E; Yamauchi M; Hiramatsu A; Imamura M; Chayama K; Aikata H
Oncology; 2019; 97(2):75-81. PubMed ID: 31242488
[TBL] [Abstract][Full Text] [Related]
29. Acute acalculous cholecystitis following COVID-19 vaccination: a case report.
Kyungu FM; Katumba AM; Kamwira HL; Mayikuli AV; Mala A; Banza MI; Manirou HM; Tosali FB; Mulenga PC
Pan Afr Med J; 2022; 41():291. PubMed ID: 35855047
[TBL] [Abstract][Full Text] [Related]
30. Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
Ikeda M; Okusaka T; Mitsunaga S; Ueno H; Tamai T; Suzuki T; Hayato S; Kadowaki T; Okita K; Kumada H
Clin Cancer Res; 2016 Mar; 22(6):1385-94. PubMed ID: 26500236
[TBL] [Abstract][Full Text] [Related]
31. Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma.
Ikeda A; Aoki K; Kawamura M; Yamaguchi D; Kokuryu H
Intern Med; 2021; 60(3):403-407. PubMed ID: 33518611
[TBL] [Abstract][Full Text] [Related]
32. [Perforated acute acalculous cholecystitis caused by hepatitis A].
Cuk P; Iqbal M; Lykke J
Ugeskr Laeger; 2014 Apr; 176(16):. PubMed ID: 25351402
[TBL] [Abstract][Full Text] [Related]
33. [A case of advanced hepatocellular carcinoma wherein readministration was made possible due to successful transcatheter arterial embolization for intratumoral hemorrhage during Lenvatinib administration].
Hara H; Nakano Y; Arai K; Kaneko Y; Sakaki K; Fukami Y; Ikemiyagi H; Yoshino K; Sakita S
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(5):476-485. PubMed ID: 35545547
[TBL] [Abstract][Full Text] [Related]
34. Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.
Peng W; Wu Y; Zhang X; Li C; Shen J; Chen W; Li Q; Ma J; Yang Y; Lu W; Liu Z; Sun X; Yang J; Zhou Y; Wen T
Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38447209
[No Abstract] [Full Text] [Related]
35. Sorafenib
Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
Anticancer Res; 2020 Apr; 40(4):2283-2290. PubMed ID: 32234927
[TBL] [Abstract][Full Text] [Related]
36. Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
Kotani K; Enomoto M; Okada M; Yoshida K; Motoyama H; Fujii H; Hagihara A; Uchida-Kobayashi S; Morikawa H; Murakami Y; Tamori A; Kawada N
Clin J Gastroenterol; 2019 Aug; 12(4):355-360. PubMed ID: 31020569
[TBL] [Abstract][Full Text] [Related]
37. Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?
Oikonomopoulos G; Aravind P; Sarker D
Future Oncol; 2016 Feb; 12(4):465-76. PubMed ID: 26785762
[TBL] [Abstract][Full Text] [Related]
38. Acute acalculous cholecystitis with pericholecystitis in a patient with Epstein-Barr Virus infectious mononucleosis.
Chalupa P; Kaspar M; Holub M
Med Sci Monit; 2009 Feb; 15(2):CS30-33. PubMed ID: 19179974
[TBL] [Abstract][Full Text] [Related]
39. Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression.
Fu R; Jiang S; Li J; Chen H; Zhang X
Med Oncol; 2020 Mar; 37(4):24. PubMed ID: 32166604
[TBL] [Abstract][Full Text] [Related]
40. Acalculous acute cholecystitis during the course of an enteroviral infection.
Simões AS; Marinhas A; Coelho P; Ferreira S
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30975776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
